Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10662124 | 0.97 | CA12 (0.54) | CA12CA1CA9CA2MGLL | |
| SCHEMBL10666369 | 0.97 | CA12 (0.54) | CA12CA1CA9CA2MGLL | |
| SCHEMBL10665872 | 0.97 | CA12 (0.54) | CA12CA1CA9CA2MGLL | |
| SCHEMBL10664150 | 0.92 | CA12 (0.48) | CA12CA1CA9CA2MGLL | |
| SCHEMBL11221777 | 0.81 | CA12 (0.52) | CA12CA1CA9CA2MGLL | |
| SCHEMBL10664597 | 0.79 | CA12 (0.48) | CA12CA1CA9CA2ALDH1A1 | |
| SCHEMBL26042369 | 0.77 | CA12 (0.45) | CA12CA1CA9CA2MGLL | |
| SCHEMBL19228775 | 0.77 | MGLL (0.50) | CA12CA1CA9CA2MGLL | |
| SCHEMBL27357618 | 0.77 | CA12 (0.50) | CA12CA1CA9CA2MGLL | |
| SCHEMBL12506396 | 0.75 | CA12 (0.43) | CA12CA1CA9CA2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345945-B1 | MODIFIED MONOMER, MODIFIED CONJUGATED DIENE-BASED POLYMER COMPRISING SAME, AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2022-11-30 | — | — | EP | disclosed |
| US-10662143-B2 | Modification monomer, modified conjugated diene-based polymer including the same and method for preparing the polymer | LG CHEM, LTD. (KR) | 2020-05-26 | — | — | US | disclosed |
| US-20190071390-A1 | MODIFICATION MONOMER, MODIFIED CONJUGATED DIENE-BASED POLYMER INCLUDING THE SAME AND METHOD FOR PREPARING THE POLYMER | LG CHEM, LTD. (KR) | 2019-03-07 | — | — | US | disclosed |
| EP-3345945-A1 | MODIFIED MONOMER, MODIFIED CONJUGATED DIENE-BASED POLYMER COMPRISING SAME, AND METHOD FOR PREPARING SAME | LG Chem, Ltd. (KR) | 2018-07-11 | — | — | EP | disclosed |
| US-4719245-A | TRIMERIZATION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1988-01-12 | — | — | US | disclosed |
| US-4703099-A | CATALYTICALLY TRIMERIZING ISOCYANATES | THE DOW CHEMICAL COMPANY (US) | 1987-10-27 | — | — | US | disclosed |
| US-4632989-A | KETENE AMINAL-OLEFIN REACTION PRODUCT AS CATALYSTS | THE DOW CHEMICAL COMPANY (US) | 1986-12-30 | — | — | US | disclosed |
| US-4536490-A | REACTION PRODUCT OF KETENE-AMINAL AND UNSATURATED COMPOUND | THE UPJOHN COMPANY (US) | 1985-08-20 | — | — | US | disclosed |
| US-4342841-A | Polyamide polyurethane prepared by reaction of polyisocyanate with a 1,1-diamino ethylene | THE UPJOHN COMPANY (US) | 1982-08-03 | — | — | US | disclosed |
| US-4338428-A | Novel polyamides from ketene-aminals | THE UPJOHN COMPANY (US) | 1982-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662143-B2 | Modification monomer, modified conjugated diene-based polymer including the same and method for preparing the polymer | NOTUM, CARM1, FAR1 | CA12 1366/4885CA1 2278/4885CA9 3205/4885 |
| US-20190071390-A1 | MODIFICATION MONOMER, MODIFIED CONJUGATED DIENE-BASED POLYMER INCLUDING THE SAME AND METHOD FOR PREPARING THE POLYMER | NOTUM, CARM1, FAR1 | CA12 1366/4885CA1 2278/4885CA9 3205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.